This study is looking at a new way to treat lung cancer using a device called CivaSheet. CivaSheet delivers radiation directly to the tumor, similar to standard treatments but in a different setup. The goal is to see if CivaSheet can effectively treat lung cancer while reducing radiation exposure to important organs like your heart. We are looking for up to 40 participants who have non-small cell lung cancer (NSCLC) in the upper parts of their lungs, with a tumor size of 7 cm or less, and who are in clinical stage I or II. The main way we'll know if the treatment is successful is by checking how well the cancer is controlled in the treated area after one year. The current status of this study is unclear.

Study design

This is a feasibility study, meaning it's an early look at how well a new treatment works. It aims to enroll up to 40 participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The study will measure how well the cancer is controlled at one year after treatment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.